These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 20420831

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T, Naka T.
    Invest Ophthalmol Vis Sci; 2011 May 17; 52(6):3264-71. PubMed ID: 21330657
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, Ohsugi Y, Nishikawa T, Ripley B, Kimura A, Kishimoto T, Naka T.
    Arthritis Rheum; 2008 Dec 17; 58(12):3710-9. PubMed ID: 19035481
    [Abstract] [Full Text] [Related]

  • 4. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
    Yokoi H, Kato K, Kezuka T, Sakai J, Usui M, Yagita H, Okumura K.
    Eur J Immunol; 1997 Mar 17; 27(3):641-6. PubMed ID: 9079803
    [Abstract] [Full Text] [Related]

  • 5. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
    Sartani G, Silver PB, Rizzo LV, Chan CC, Wiggert B, Mastorakos G, Caspi RR.
    Invest Ophthalmol Vis Sci; 1996 Oct 17; 37(11):2211-8. PubMed ID: 8843907
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H, Strassmann G, Chan CC, Rizzo LV, Silver PB, Wiggert B, Caspi RR.
    Invest Ophthalmol Vis Sci; 1999 Apr 17; 40(5):942-50. PubMed ID: 10102291
    [Abstract] [Full Text] [Related]

  • 7. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M, Yang P, Du L, Zhou H, Ren X, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2010 Jan 17; 51(1):383-9. PubMed ID: 19696173
    [Abstract] [Full Text] [Related]

  • 8. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C, Fujimoto M, Nomura S, Serada S, Nakai K, Ohguro N, Nishida K, Naka T.
    Exp Eye Res; 2015 Nov 17; 140():53-64. PubMed ID: 26297802
    [Abstract] [Full Text] [Related]

  • 9. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis.
    Keino H, Watanabe T, Sato Y, Okada AA.
    Br J Ophthalmol; 2010 Jun 17; 94(6):802-7. PubMed ID: 19965837
    [Abstract] [Full Text] [Related]

  • 10. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K, Matsumoto I, Tanaka-Watanabe Y, Inoue A, Mihara M, Ohsugi Y, Mamura M, Goto D, Ito S, Tsutsumi A, Kishimoto T, Sumida T.
    Arthritis Rheum; 2008 Mar 17; 58(3):754-63. PubMed ID: 18311788
    [Abstract] [Full Text] [Related]

  • 11. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H, Sakai T, Tsuneoka H, Imanishi K, Saito S.
    Exp Eye Res; 2009 Oct 17; 89(4):486-93. PubMed ID: 19523946
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.
    Kitaichi N, Matsuda A, Kotake S, Namba K, Tagawa Y, Sasamoto Y, Ogasawara K, Iwabuchi K, Onoé K, Matsuda H, Nishihira J.
    Curr Eye Res; 2000 Feb 17; 20(2):109-14. PubMed ID: 10617911
    [Abstract] [Full Text] [Related]

  • 13. Effects of systemic and intravitreal TNF-α inhibition in experimental autoimmune uveoretinitis.
    Busch M, Bauer D, Hennig M, Wasmuth S, Thanos S, Heiligenhaus A.
    Invest Ophthalmol Vis Sci; 2013 Jan 02; 54(1):39-46. PubMed ID: 23211816
    [Abstract] [Full Text] [Related]

  • 14. Suppression of experimental autoimmune uveoretinitis by Anti-IL-17 antibody.
    Zhang R, Qian J, Guo J, Yuan YF, Xue K.
    Curr Eye Res; 2009 Apr 02; 34(4):297-303. PubMed ID: 19373578
    [Abstract] [Full Text] [Related]

  • 15. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H, Kezuka T, Takeuchi M, Yamakawa N, Hattori T, Usui M.
    Arch Ophthalmol; 2004 Aug 02; 122(8):1179-84. PubMed ID: 15302659
    [Abstract] [Full Text] [Related]

  • 16. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A, Usui Y, Takeuchi M, Hattori T, Kezuka T, Suzuki J, Okunuki Y, Iwasaki T, Haino M, Matsushima K, Usui M.
    Invest Ophthalmol Vis Sci; 2005 Oct 02; 46(10):3753-60. PubMed ID: 16186359
    [Abstract] [Full Text] [Related]

  • 17. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K, Byoun OJ, Ham DI, Kim YS, Lee DS.
    Eur J Immunol; 2011 Feb 02; 41(2):392-402. PubMed ID: 21268009
    [Abstract] [Full Text] [Related]

  • 18. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis.
    Suzuki J, Sakai J, Okada AA, Takada E, Usui M, Mizuguchi J.
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr 02; 240(4):314-21. PubMed ID: 11981647
    [Abstract] [Full Text] [Related]

  • 19. Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA.
    Iwata D, Kitamura M, Kitaichi N, Saito Y, Kon S, Namba K, Morimoto J, Ebihara A, Kitamei H, Yoshida K, Ishida S, Ohno S, Uede T, Onoé K, Iwabuchi K.
    Exp Eye Res; 2010 Jan 02; 90(1):41-8. PubMed ID: 19766630
    [Abstract] [Full Text] [Related]

  • 20. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB.
    J Immunol; 1988 Mar 01; 140(5):1490-5. PubMed ID: 3346541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.